Cargando…
Hypoxia-induced RBBP7 promotes esophagus cancer progression by inducing CDK4 expression: RBBP7 promotes esophagus cancer progression
Hypoxia-induced epigenetic regulation calls for more effective therapeutic targets for esophageal cancer. We used GEPIA and UALCAN databases to screen survival-related and cancer stage-associated genes. Eca109 and KYSE450 esophageal cancer cell lines were cultured under normoxia, hypoxia, or CoCl (2...
Autores principales: | Wang, Renfeng, Huang, Zhiliang, Lin, Zhenyang, Chen, Borong, Pang, Xuguang, Du, Chaoxiang, Fan, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909297/ https://www.ncbi.nlm.nih.gov/pubmed/35538026 http://dx.doi.org/10.3724/abbs.2021027 |
Ejemplares similares
-
RBBP4 promotes colon cancer malignant progression via regulating Wnt/β-catenin pathway
por: Li, Yan-Dong, et al.
Publicado: (2020) -
RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Yu, Ning, et al.
Publicado: (2018) -
X-linked RBBP7 mutation causes maturation arrest and testicular tumors
por: Li, Jingping, et al.
Publicado: (2023) -
Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research
por: Cai, Lize, et al.
Publicado: (2023) -
Identifying RBBP7 as a Promising Diagnostic Biomarker for BK Virus-Associated Nephropathy
por: Wang, Yicun, et al.
Publicado: (2022)